Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tralokinumab in Moderate to Severe Alopecia Areata
NCT02684097Phase 2Completed
- Start
- Jan 2016
- Primary completion
- Nov 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tralokinumab in alopecia areata. Started Jan 2016; status: completed.
02
Drugs
tralokinumab
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02684097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684097.